These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16311)
21. [Analysis of anxiolytic and hypnotic use in hospital departments]. Lövy O; Elis J; Richter M; Stika L Cesk Zdrav; 1980 Sep; 28(8-9):341-6. PubMed ID: 6106531 [No Abstract] [Full Text] [Related]
22. Interactions between anxiety, social support, health status and buspirone efficacy in elderly patients. Majercsik E; Haller J Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1161-9. PubMed ID: 15610929 [TBL] [Abstract][Full Text] [Related]
23. [Determination of optimal posology for hypnotic and anxiolytic agents]. Dreyfus JF; Puech J; Simon P; Boulenger JP; Couzinier JP; Garreau M; Guelfi JD; Guichoux JY; Hecquet S; Lefur G J Pharmacol; 1986; 17 Suppl 1():19-24. PubMed ID: 2875221 [No Abstract] [Full Text] [Related]
24. [Clobazam (Frisium) in everyday practice. An open six-months' study of its efficacy and tolerance (author's transl)]. Radmayr E; Koeppen D MMW Munch Med Wochenschr; 1977 Dec; 119(50):1623-6. PubMed ID: 23493 [TBL] [Abstract][Full Text] [Related]
26. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis. Stokes DK J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769 [TBL] [Abstract][Full Text] [Related]
27. [Open study of bromapezan in ambulatory and psychiatric hospital patients (author's transl)]. Singer L; Danion JM; Roos M; Levy A; Wetta JM; Singer P; Lehr D; Ferretto JL; Keppi J; Bouhey J Nouv Presse Med; 1982 May; 11(22):1725-7. PubMed ID: 6124943 [TBL] [Abstract][Full Text] [Related]
28. Measurement of anxiety in outpatient trials: detection of bias in patient and doctor ratings. Fisher S Psychopharmacol Bull; 1976 Apr; 12(2):17-8. PubMed ID: 3818 [No Abstract] [Full Text] [Related]
30. A preliminary double-blind study with SB 5833 (camazepam), a new benzodiazepine derivative. Cesa-Bianchi M; Ghirardi P; Ravaccia F Arzneimittelforschung; 1974 Dec; 24(12):2032-5. PubMed ID: 4156178 [No Abstract] [Full Text] [Related]
31. Choice of rating form for evaluating anxiolytics. Wang RI; Kochar C Psychopharmacol Bull; 1989; 25(2):291-5. PubMed ID: 2574898 [TBL] [Abstract][Full Text] [Related]
32. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology. Berkowitz JM J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768 [TBL] [Abstract][Full Text] [Related]
34. Effect of clorazepate on depressed mood in anxious patients. Zung WW J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832 [TBL] [Abstract][Full Text] [Related]
35. Item analysis of the differences in comparative drug effects as yielded by the self-rating questionnaire SCL-90. Boleloucký Z; Plevová J; Kamenická V; Náhunek K Act Nerv Super (Praha); 1979 Sep; 21(2):123-4. PubMed ID: 42256 [No Abstract] [Full Text] [Related]
36. Abuse liability of anxiolytics and sedative/hypnotics: methods assessing the likelihood of abuse. Roache JD; Griffiths RR NIDA Res Monogr; 1989; 92():123-46. PubMed ID: 2574414 [No Abstract] [Full Text] [Related]
37. Differential psychopharmacology of tranquilizing and sedating drugs. Janke W; Debus G; Longo N Mod Probl Pharmacopsychiatry; 1979; 14():13-98. PubMed ID: 33327 [No Abstract] [Full Text] [Related]
38. Clinical assessment of lorazepam in anxiety: a double-blind study. Olgiati SG Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741 [No Abstract] [Full Text] [Related]
39. [Double-blind trial treatment of anxiety with b 5833]. Cloquette R Acta Psychiatr Belg; 1974 May; 74(3):317-26. PubMed ID: 4156149 [No Abstract] [Full Text] [Related]